# ReproTech, LLC. – FDA Inspection, Mar 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/reprotech-llc/64a4e390-3acf-42cf-9a52-72646c253687
Source feed: FDA_Inspections

> FDA inspection 1082797 of ReproTech, LLC., March 06, 2019. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082797
- Company Name: ReproTech, LLC.
- Inspection Date: 2019-03-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1228932 - 2024-02-08
- [FDA Inspection 987795 - 2016-05-04](https://www.keypedia.com/records/fda_inspections/reprotech-llc/a9e79306-4118-4467-a3cb-30443659a394)
- FDA Inspection 889756 - 2014-08-04

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/ivan-e-reyes/69bac3eb-f63c-45f0-8420-85a7e06b884a)

Company: https://www.keypedia.com/companies/reprotech-llc/ba750420-12a4-4711-a78c-1093c00b5a1d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d